semaglutide weight loss average A diabetes drug. Then a weight-loss drug. Then a global blockbuster. Here's how GLP-1s went from helping manage blood sugar to becoming one of medicine's biggest stories. [GLP-1, Ozempic, Wegovy, Mounjaro, diabetes Semaglutide for Weight Loss: What

Wegovy is indicated for adults with BMI 30 kg/m or 27 kg/m with at least one weight-related condition, and for adolescents aged 12 and older with BMI 95th percentile for age and sex

Genetic variants including GIPR rs1800437 , GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 relate to the biological pathways these medications act on

Both medication classes can cause gastrointestinal side effects, and taking them together might intensify symptoms such as nausea, vomiting, or diarrhea

Research Support and Efficacy Numerous clinical trials have demonstrated the effectiveness of semaglutide for weight loss: Clinical Trials : In a pivotal study involving approximately 2,000 adults with obesity or overweight (without diabetes), those using semaglutide in conjunction with lifestyle modifications lost an average of 14.9% of their body weight over 68 weeks, compared to a mere 2.4% weight loss in the placebo group

The article's table puts non-exercising patients at roughly 0.7 to 1.2 pounds a week, and says those adding 150 or more minutes a week of moderate activity may see that accelerate to 1.5 to 2.5 pounds